{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:39:36Z","timestamp":1777084776632,"version":"3.51.4"},"reference-count":52,"publisher":"American Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>Rabbits are widely used in biomedical research as models for atherosclerosis with disease induction achieved through a high-cholesterol diet, transgenic approaches, or spontaneous development with aging. At our institution, New Zealand White rabbits were induced to develop atherosclerosis via a high-cholesterol diet followed by arterial balloon injury. This model was established to support intravascular molecular imaging studies aimed at tracking atheromatous plaque progression in vivo. To accelerate plaque development, a subcutaneous osmotic pump delivering angiotensin II at 50 ng\/kg\/min was implanted. While this method enhanced disease progression, unexpected clinical complications were observed. In this retrospective case report, we reviewed clinical records from 54 rabbits over a 2-year period. Clinically, most study animals showed different levels of inappetence. Three presented respiratory symptoms including cyanosis, dyspnea, or tachypnea, while another 3 exhibited neurologic signs such as altered mentation and paralysis. Eight rabbits (14.8%) were euthanized due to severe clinical signs. Necropsy findings in the affected animals commonly revealed pleural and\/or peritoneal effusion; one case included chyloabdomen, a condition not previously reported in rabbits. Of these, 7 had myocardial degeneration and fibrosis. These findings suggest that angiotensin II infusion in this rabbit model of atherosclerosis may induce myocardial fibrosis as a significant adverse effect. This report highlights potential complications associated with the model and provides guidance for clinical monitoring, diagnosis, and management in future studies.<\/jats:p>","DOI":"10.30802\/aalas-jaalas-25-155","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:51:13Z","timestamp":1770771073000},"page":"232-238","source":"Crossref","is-referenced-by-count":0,"title":["Myocardial Fibrosis Caused by Angiotensin II Implant in Rabbit Atherosclerosis Model Induced by High Cholesterol Diet"],"prefix":"10.30802","volume":"65","author":[{"given":"Dimitria","family":"Gomes","sequence":"first","affiliation":[{"name":"Center for Comparative Medicine, Massachusetts General Hospital, Charlestown, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Kizielewicz","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, Massachusetts General Hospital, Charlestown, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Morris","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, Massachusetts General Hospital, Charlestown, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Beale","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, Massachusetts General Hospital, Charlestown, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Mauskapf","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farouc A","family":"Jaffer","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine Yu","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lester","sequence":"additional","affiliation":[{"name":"Unit for Laboratory Animal Medicine, School of Medicine, University of Michigan, Ann Arbor, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jibing","family":"Yang","sequence":"additional","affiliation":[{"name":"Center for Comparative Medicine, Massachusetts General Hospital, Charlestown, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"12258","reference":[{"key":"bib1","series-title":"Atherosclerosis.","first-page":"119131","article-title":"Environmental pollutants and atherosclerosis: epigenetic mechanisms linking genetic risk and disease","volume":"404","author":"Damiani I","year":"2025","unstructured":"Damiani I, Solberg EH, Iyer M, et al. Environmental pollutants and atherosclerosis: epigenetic mechanisms linking genetic risk and disease. Atherosclerosis. 2025;404:119131."},{"issue":"8","key":"bib2","series-title":"Trends Mol Med.","first-page":"362","article-title":"USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome","volume":"10","author":"Shoulders CC","year":"2004","unstructured":"Shoulders CC, Naoumova RP. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med. 2004;10(8):362\u2013365."},{"key":"bib3","series-title":"Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000\u20132019.","year":"2020","unstructured":"World Health Organization. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000\u20132019. World Health Organization; 2020."},{"issue":"12","key":"bib4","series-title":"Circulation.","first-page":"916","article-title":"Prevalence of subclinical coronary artery atherosclerosis in the general population","volume":"144","author":"Bergstrom G","year":"2021","unstructured":"Bergstrom G, Persson M, Adiels M, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144(12):916\u2013929."},{"key":"bib5","series-title":"NPJ Aging Mech Dis.","first-page":"7","article-title":"The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy","volume":"4","author":"Ikegami Y","year":"2018","unstructured":"Ikegami Y, Inoue I, Inoue K, et al. The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy. NPJ Aging Mech Dis. 2018;4:7."},{"key":"bib6","series-title":"Clin Res Cardiol.","article-title":"PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography: a meta-analysis","author":"Sagris M","year":"2025","unstructured":"Sagris M, de Isla LP, Korosoglou G. PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography: a meta-analysis. Clin Res Cardiol. 2025; In press."},{"key":"bib7","series-title":"Animal Models for the Study of Human Disease.","author":"Conn PM","year":"2017","unstructured":"Conn PM. Animal Models for the Study of Human Disease. Academic Press; 2017."},{"issue":"5","key":"bib8","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"1104","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz GS","year":"2012","unstructured":"Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(5):1104\u20131115."},{"issue":"2","key":"bib9","series-title":"Transl Res.","first-page":"99","article-title":"Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis","volume":"163","author":"Fang L","year":"2014","unstructured":"Fang L, Liu C, Miller YI. Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis. Transl Res. 2014;163(2):99\u2013108."},{"key":"bib10","series-title":"The ESC Textbook of Vascular Biology.","first-page":"53","article-title":"Animal models to study pathophysiology of the vasculature.","author":"Gu W","year":"2017","unstructured":"Gu W, Xie Y, Xu Q. Animal models to study pathophysiology of the vasculature. In: Krams R, B\u00e4ck M, eds. The ESC Textbook of Vascular Biology. Oxford University Press; 2017:53\u201368."},{"issue":"6","key":"bib11","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"1068","article-title":"Deficiency of cholesteryl ester transfer protein protects against atherosclerosis in rabbits","volume":"37","author":"Zhang J","year":"2017","unstructured":"Zhang J, Niimi M, Yang D, et al. Deficiency of cholesteryl ester transfer protein protects against atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 2017;37(6):1068\u20131075."},{"issue":"8A","key":"bib12","series-title":"Am J Cardiol.","first-page":"25c","article-title":"Angiotensin II and atherosclerosis","volume":"87","author":"Weiss D","year":"2001","unstructured":"Weiss D, Sorescu D, Taylor WR. Angiotensin II and atherosclerosis. Am J Cardiol. 2001;87(8A):25c\u201332c."},{"issue":"12","key":"bib13","series-title":"JACC Cardiovasc Imaging.","first-page":"1327","article-title":"The advancing clinical impact of molecular imaging in CVD","volume":"6","author":"Osborn EA","year":"2013","unstructured":"Osborn EA, Jaffer FA. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging. 2013;6(12):1327\u20131341."},{"issue":"4","key":"bib14","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"757","article-title":"Lipid-lowering therapy with ezetimibe decreases spontaneous atherothrombotic occlusions in a rabbit model of plaque erosion: a role of serum oxysterols","volume":"38","author":"Honda K","year":"2018","unstructured":"Honda K, Matoba T, Antoku Y, et al. Lipid-lowering therapy with ezetimibe decreases spontaneous atherothrombotic occlusions in a rabbit model of plaque erosion: a role of serum oxysterols. Arterioscler Thromb Vasc Biol. 2018;38(4):757\u2013771."},{"issue":"2","key":"bib15","series-title":"Cardiovasc Drugs Ther.","first-page":"311","article-title":"Furosemide dynamics in conscious rabbits: modulation by angiotensin II","volume":"9","author":"Homsy W","year":"1995","unstructured":"Homsy W, Marleau S, Du Souich P. Furosemide dynamics in conscious rabbits: modulation by angiotensin II. Cardiovasc Drugs Ther. 1995;9(2):311\u2013317."},{"issue":"3","key":"bib16","series-title":"Vet Clin Pathol.","first-page":"80","article-title":"Lipoprotein electrophoresis differentiation of chylous and nonchylous pleural effusions in dogs and cats and its correlation with pleural effusion triglyceride concentration","volume":"19","author":"Waddle JR","year":"1990","unstructured":"Waddle JR, Giger U. Lipoprotein electrophoresis differentiation of chylous and nonchylous pleural effusions in dogs and cats and its correlation with pleural effusion triglyceride concentration. Vet Clin Pathol. 1990;19(3):80\u201385."},{"issue":"5","key":"bib17","series-title":"J Am Assoc Lab Anim Sci.","first-page":"495","article-title":"Comparison of effects of capromorelin and mirtazapine on appetite in New Zealand White rabbits (Oryctolagus cuniculus)","volume":"61","author":"Draper JM","year":"2022","unstructured":"Draper JM, Savson DJ, Lavin ES, et al. Comparison of effects of capromorelin and mirtazapine on appetite in New Zealand White rabbits (Oryctolagus cuniculus). J Am Assoc Lab Anim Sci. 2022;61(5):495\u2013505."},{"issue":"6","key":"bib18","series-title":"J Am Vet Med Assoc.","first-page":"755","article-title":"The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus)","volume":"263","author":"Di Girolamo N","year":"2025","unstructured":"Di Girolamo N, Maranville RE, Pathak D, et al. The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus). J Am Vet Med Assoc. 2025;263(6):755\u2013761."},{"issue":"11","key":"bib19","series-title":"J Clin Invest.","first-page":"1605","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty A","year":"2000","unstructured":"Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105(11):1605\u20131612."},{"issue":"3","key":"bib20","series-title":"Circulation.","first-page":"448","article-title":"Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice","volume":"103","author":"Weiss D","year":"2001","unstructured":"Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation. 2001;103(3):448\u2013454."},{"key":"bib21","series-title":"The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents.","first-page":"503","author":"Kristie Brock LG","year":"2012","unstructured":"Kristie Brock LG, Bergdall VK, Dysko RC. The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. American College of Laboratory Animal Medicine; 2012:503\u2013528."},{"issue":"5","key":"bib22","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"810","article-title":"Angiotensin II destabilizes coronary plaques in Watanabe heritable hyperlipidemic rabbits","volume":"36","author":"Li S","year":"2016","unstructured":"Li S, Wang YN, Niimi M, et al. Angiotensin II destabilizes coronary plaques in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2016;36(5):810\u2013816."},{"issue":"11","key":"bib23","series-title":"J Am Soc Nephrol.","first-page":"2783","article-title":"Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II","volume":"14","author":"Wang D","year":"2003","unstructured":"Wang D, Chen Y, Chabrashvili T, et al. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol. 2003;14(11):2783\u20132789."},{"key":"bib24","series-title":"Pathology of Laboratory Rodents and Rabbits.","author":"Percy DH","year":"2013","unstructured":"Percy DH, Barthold SW. Pathology of Laboratory Rodents and Rabbits. Wiley; 2013."},{"issue":"9","key":"bib25","series-title":"Companion Anim.","first-page":"534","article-title":"Idiopathic chylothorax in a pet rabbit (Oryctolagus cuniculus)","volume":"21","author":"Levshin S","year":"2016","unstructured":"Levshin S, Eshar D, Naor A. Idiopathic chylothorax in a pet rabbit (Oryctolagus cuniculus). Companion Anim. 2016;21(9):534\u2013537."},{"issue":"7","key":"bib26","series-title":"J Am Vet Med Assoc.","first-page":"886","article-title":"Incidence of chyloabdomen diagnosis in dogs and cats and corresponding clinical signs, clinicopathologic test results, and outcomes: 53 cases (1984\u20132014)","volume":"253","author":"Hatch A","year":"2018","unstructured":"Hatch A, Jandrey KE, Tenwolde MC, et al. Incidence of chyloabdomen diagnosis in dogs and cats and corresponding clinical signs, clinicopathologic test results, and outcomes: 53 cases (1984\u20132014). J Am Vet Med Assoc. 2018;253(7):886\u2013892."},{"key":"bib1","series-title":"Atherosclerosis.","first-page":"119131","article-title":"Environmental pollutants and atherosclerosis: epigenetic mechanisms linking genetic risk and disease","volume":"404","author":"Damiani I","year":"2025","unstructured":"Damiani I, Solberg EH, Iyer M, et al. Environmental pollutants and atherosclerosis: epigenetic mechanisms linking genetic risk and disease. Atherosclerosis. 2025;404:119131."},{"issue":"8","key":"bib2","series-title":"Trends Mol Med.","first-page":"362","article-title":"USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome","volume":"10","author":"Shoulders CC","year":"2004","unstructured":"Shoulders CC, Naoumova RP. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med. 2004;10(8):362\u2013365."},{"key":"bib3","series-title":"Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000\u20132019.","year":"2020","unstructured":"World Health Organization. Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000\u20132019. World Health Organization; 2020."},{"issue":"12","key":"bib4","series-title":"Circulation.","first-page":"916","article-title":"Prevalence of subclinical coronary artery atherosclerosis in the general population","volume":"144","author":"Bergstrom G","year":"2021","unstructured":"Bergstrom G, Persson M, Adiels M, et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144(12):916\u2013929."},{"key":"bib5","series-title":"NPJ Aging Mech Dis.","first-page":"7","article-title":"The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy","volume":"4","author":"Ikegami Y","year":"2018","unstructured":"Ikegami Y, Inoue I, Inoue K, et al. The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy. NPJ Aging Mech Dis. 2018;4:7."},{"key":"bib6","series-title":"Clin Res Cardiol.","article-title":"PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography: a meta-analysis","author":"Sagris M","year":"2025","unstructured":"Sagris M, de Isla LP, Korosoglou G. PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography: a meta-analysis. Clin Res Cardiol. 2025; In press."},{"key":"bib7","series-title":"Animal Models for the Study of Human Disease.","author":"Conn PM","year":"2017","unstructured":"Conn PM. Animal Models for the Study of Human Disease. Academic Press; 2017."},{"issue":"5","key":"bib8","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"1104","article-title":"Animal models of atherosclerosis","volume":"32","author":"Getz GS","year":"2012","unstructured":"Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(5):1104\u20131115."},{"issue":"2","key":"bib9","series-title":"Transl Res.","first-page":"99","article-title":"Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis","volume":"163","author":"Fang L","year":"2014","unstructured":"Fang L, Liu C, Miller YI. Zebrafish models of dyslipidemia: relevance to atherosclerosis and angiogenesis. Transl Res. 2014;163(2):99\u2013108."},{"key":"bib10","series-title":"The ESC Textbook of Vascular Biology.","first-page":"53","article-title":"Animal models to study pathophysiology of the vasculature.","author":"Gu W","year":"2017","unstructured":"Gu W, Xie Y, Xu Q. Animal models to study pathophysiology of the vasculature. In: Krams R, B\u00e4ck M, eds. The ESC Textbook of Vascular Biology. Oxford University Press; 2017:53\u201368."},{"issue":"6","key":"bib11","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"1068","article-title":"Deficiency of cholesteryl ester transfer protein protects against atherosclerosis in rabbits","volume":"37","author":"Zhang J","year":"2017","unstructured":"Zhang J, Niimi M, Yang D, et al. Deficiency of cholesteryl ester transfer protein protects against atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 2017;37(6):1068\u20131075."},{"issue":"8A","key":"bib12","series-title":"Am J Cardiol.","first-page":"25c","article-title":"Angiotensin II and atherosclerosis","volume":"87","author":"Weiss D","year":"2001","unstructured":"Weiss D, Sorescu D, Taylor WR. Angiotensin II and atherosclerosis. Am J Cardiol. 2001;87(8A):25c\u201332c."},{"issue":"12","key":"bib13","series-title":"JACC Cardiovasc Imaging.","first-page":"1327","article-title":"The advancing clinical impact of molecular imaging in CVD","volume":"6","author":"Osborn EA","year":"2013","unstructured":"Osborn EA, Jaffer FA. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc Imaging. 2013;6(12):1327\u20131341."},{"issue":"4","key":"bib14","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"757","article-title":"Lipid-lowering therapy with ezetimibe decreases spontaneous atherothrombotic occlusions in a rabbit model of plaque erosion: a role of serum oxysterols","volume":"38","author":"Honda K","year":"2018","unstructured":"Honda K, Matoba T, Antoku Y, et al. Lipid-lowering therapy with ezetimibe decreases spontaneous atherothrombotic occlusions in a rabbit model of plaque erosion: a role of serum oxysterols. Arterioscler Thromb Vasc Biol. 2018;38(4):757\u2013771."},{"issue":"2","key":"bib15","series-title":"Cardiovasc Drugs Ther.","first-page":"311","article-title":"Furosemide dynamics in conscious rabbits: modulation by angiotensin II","volume":"9","author":"Homsy W","year":"1995","unstructured":"Homsy W, Marleau S, Du Souich P. Furosemide dynamics in conscious rabbits: modulation by angiotensin II. Cardiovasc Drugs Ther. 1995;9(2):311\u2013317."},{"issue":"3","key":"bib16","series-title":"Vet Clin Pathol.","first-page":"80","article-title":"Lipoprotein electrophoresis differentiation of chylous and nonchylous pleural effusions in dogs and cats and its correlation with pleural effusion triglyceride concentration","volume":"19","author":"Waddle JR","year":"1990","unstructured":"Waddle JR, Giger U. Lipoprotein electrophoresis differentiation of chylous and nonchylous pleural effusions in dogs and cats and its correlation with pleural effusion triglyceride concentration. Vet Clin Pathol. 1990;19(3):80\u201385."},{"issue":"5","key":"bib17","series-title":"J Am Assoc Lab Anim Sci.","first-page":"495","article-title":"Comparison of effects of capromorelin and mirtazapine on appetite in New Zealand White rabbits (Oryctolagus cuniculus)","volume":"61","author":"Draper JM","year":"2022","unstructured":"Draper JM, Savson DJ, Lavin ES, et al. Comparison of effects of capromorelin and mirtazapine on appetite in New Zealand White rabbits (Oryctolagus cuniculus). J Am Assoc Lab Anim Sci. 2022;61(5):495\u2013505."},{"issue":"6","key":"bib18","series-title":"J Am Vet Med Assoc.","first-page":"755","article-title":"The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus)","volume":"263","author":"Di Girolamo N","year":"2025","unstructured":"Di Girolamo N, Maranville RE, Pathak D, et al. The 4 prokinetic drugs metoclopramide, cisapride, pyridostigmine, and capromorelin do not increase fecal output or food intake in healthy New Zealand rabbits (Oryctolagus cuniculus). J Am Vet Med Assoc. 2025;263(6):755\u2013761."},{"issue":"11","key":"bib19","series-title":"J Clin Invest.","first-page":"1605","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty A","year":"2000","unstructured":"Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000;105(11):1605\u20131612."},{"issue":"3","key":"bib20","series-title":"Circulation.","first-page":"448","article-title":"Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice","volume":"103","author":"Weiss D","year":"2001","unstructured":"Weiss D, Kools JJ, Taylor WR. Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice. Circulation. 2001;103(3):448\u2013454."},{"key":"bib21","series-title":"The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents.","first-page":"503","author":"Kristie Brock LG","year":"2012","unstructured":"Kristie Brock LG, Bergdall VK, Dysko RC. The Laboratory Rabbit, Guinea Pig, Hamster, and Other Rodents. American College of Laboratory Animal Medicine; 2012:503\u2013528."},{"issue":"5","key":"bib22","series-title":"Arterioscler Thromb Vasc Biol.","first-page":"810","article-title":"Angiotensin II destabilizes coronary plaques in Watanabe heritable hyperlipidemic rabbits","volume":"36","author":"Li S","year":"2016","unstructured":"Li S, Wang YN, Niimi M, et al. Angiotensin II destabilizes coronary plaques in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2016;36(5):810\u2013816."},{"issue":"11","key":"bib23","series-title":"J Am Soc Nephrol.","first-page":"2783","article-title":"Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II","volume":"14","author":"Wang D","year":"2003","unstructured":"Wang D, Chen Y, Chabrashvili T, et al. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol. 2003;14(11):2783\u20132789."},{"key":"bib24","series-title":"Pathology of Laboratory Rodents and Rabbits.","author":"Percy DH","year":"2013","unstructured":"Percy DH, Barthold SW. Pathology of Laboratory Rodents and Rabbits. Wiley; 2013."},{"issue":"9","key":"bib25","series-title":"Companion Anim.","first-page":"534","article-title":"Idiopathic chylothorax in a pet rabbit (Oryctolagus cuniculus)","volume":"21","author":"Levshin S","year":"2016","unstructured":"Levshin S, Eshar D, Naor A. Idiopathic chylothorax in a pet rabbit (Oryctolagus cuniculus). Companion Anim. 2016;21(9):534\u2013537."},{"issue":"7","key":"bib26","series-title":"J Am Vet Med Assoc.","first-page":"886","article-title":"Incidence of chyloabdomen diagnosis in dogs and cats and corresponding clinical signs, clinicopathologic test results, and outcomes: 53 cases (1984\u20132014)","volume":"253","author":"Hatch A","year":"2018","unstructured":"Hatch A, Jandrey KE, Tenwolde MC, et al. Incidence of chyloabdomen diagnosis in dogs and cats and corresponding clinical signs, clinicopathologic test results, and outcomes: 53 cases (1984\u20132014). J Am Vet Med Assoc. 2018;253(7):886\u2013892."}],"container-title":["Journal of the American Association for Laboratory Animal Science"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/65\/2\/article-p232.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/65\/2\/article-p232.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/65\/2\/article-p232.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:59:07Z","timestamp":1777082347000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/65\/2\/article-p232.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.30802\/aalas-jaalas-25-155","relation":{},"ISSN":["1559-6109"],"issn-type":[{"value":"1559-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}